Welcome to The Gateway Pundit’s Week-in-Review with Elijah Schaffer, where he covers the top 5 stories throughout the week in around 10 minutes.
www.thegatewaypundit.com
A new study published in theNew England Journal of Medicine (NEJM) raises serious questions about the efficacy of Pfizer’s antiviral drug Paxlovid, which was previously authorized for emergency use to treat mild to moderate COVID-19 cases.
www.thegatewaypundit.com
Pfizer cuts costs after sales of its COVID-19 vaccine and oral antiviral drug Paxlovid went on a downhill
https://newstarget.com/2023-10-19-pfizer-cuts-costs-decline-covid-medication-uptake.html
Vaccine giant Pfizer has been forced to implement cost-cutting measures after a significant decline in the uptake of its Wuhan coronavirus (COVID-19) vaccine and medication over the past 12 months. According to a Pharmaphorum report, the New York-based pharmaceutical firm is set to cut costs by $1 billion this year and at least $2.5 billion […]
www.newstarget.com
There is a life-saving therapeutic called Paxlovid (Pfizer) that can save thousands of lives, yet the White House refuses to invoke the Defense Production Act to make sure it is available to all Americans now—not 3 months from now. They either don’t care or are inept.
It’s like the testing debacle all over again. It is a tragedy that so many people are suffering and dying because our leaders and bureaucrats continue to fail the American people.
A country as rich as ours should be able to provide every American with the tools and therapeutics needed to reduce suffering and save lives. Pfizer’s Paxlovid, monoclonal antibodies treatment Sotrovimab and N95 masks should be widely available to every American - but they’re not. The blood of those who are suffering and dying is on the hands of our leaders.
There is a life-saving therapeutic called Paxlovid (Pfizer) that can save thousands of lives, yet the White House refuses to invoke the Defense Production Act to make sure it is available to all Americans now—not 3 months from now. They either don’t care or are inept.
It’s like the testing debacle all over again. It is a tragedy that so many people are suffering and dying because our leaders and bureaucrats continue to fail the American people.
A country as rich as ours should be able to provide every American with the tools and therapeutics needed to reduce suffering and save lives. Pfizer’s Paxlovid, monoclonal antibodies treatment Sotrovimab and N95 masks should be widely available to every American - but they’re not. The blood of those who are suffering and dying is on the hands of our leaders.
Welcome to The Gateway Pundit’s Week-in-Review with Elijah Schaffer, where he covers the top 5 stories throughout the week in around 10 minutes.
www.thegatewaypundit.com
A new study published in theNew England Journal of Medicine (NEJM) raises serious questions about the efficacy of Pfizer’s antiviral drug Paxlovid, which was previously authorized for emergency use to treat mild to moderate COVID-19 cases.
www.thegatewaypundit.com
Pfizer cuts costs after sales of its COVID-19 vaccine and oral antiviral drug Paxlovid went on a downhill
https://newstarget.com/2023-10-19-pfizer-cuts-costs-decline-covid-medication-uptake.html
Vaccine giant Pfizer has been forced to implement cost-cutting measures after a significant decline in the uptake of its Wuhan coronavirus (COVID-19) vaccine and medication over the past 12 months. According to a Pharmaphorum report, the New York-based pharmaceutical firm is set to cut costs by $1 billion this year and at least $2.5 billion […]
www.newstarget.com
#Pfizer to #cutcosts after sales of #COVIDvaccine and #Paxlovid dropped
https://www.naturalnews.com/2023-10-19-pfizer-cuts-costs-decline-covid-medication-uptake.html
Vaccine giant Pfizer has been forced to implement cost-cutting measures after a significant decline in the uptake of its Wuhan coronavirus (COVID-19) vaccine and medication over the past 12 months. According to a Pharmaphorum report, the New York-based pharmaceutical firm is set to cut costs by $1 billion this year and at least $2.5 billion […]
www.naturalnews.com
“Something is really wrong with public health ‘leadership’ that thinks every norm can be thrown out the window in an emergency. The FDA has learned nothing during the pandemic & is setting terrible precedents for future emergencies.” — Jessica Adams, FDA regulatory affairs expert
#TheDefender
https://childrenshealthdefense.org/defender/fda-robert-califf-pfizer-covid-paxlovid/?utm_source=sovren&utm_medium=social&utm_campaign=defender&utm_id=20230821
It’s not clear why U.S. Food and Drug Administration Commissioner Robert Califf felt the need to promote the use of Paxlovid given the U.S. government had already committed to purchasing 10 million treatment courses at a cost of $5.29 billion.
childrenshealthdefense.org
0
Share on Telegram
Share on Facebook
Share on Twitter
Share on Reddit
Copy Embed Code
